Advertisement
Canada markets closed
  • S&P/TSX

    21,837.18
    -11.97 (-0.05%)
     
  • S&P 500

    5,149.42
    +32.33 (+0.63%)
     
  • DOW

    38,790.43
    +75.66 (+0.20%)
     
  • CAD/USD

    0.7382
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    82.54
    -0.18 (-0.22%)
     
  • Bitcoin CAD

    88,882.88
    -3,327.90 (-3.61%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,165.20
    +0.90 (+0.04%)
     
  • RUSSELL 2000

    2,024.74
    -14.59 (-0.72%)
     
  • 10-Yr Bond

    4.3400
    +0.0360 (+0.84%)
     
  • NASDAQ futures

    18,199.50
    -32.00 (-0.18%)
     
  • VOLATILITY

    14.33
    -0.08 (-0.56%)
     
  • FTSE

    7,722.55
    -4.87 (-0.06%)
     
  • NIKKEI 225

    39,552.55
    -187.89 (-0.47%)
     
  • CAD/EUR

    0.6787
    -0.0005 (-0.07%)
     

What Alnylam Pharmaceuticals’ Bottom Line Trend Indicates

What Alnylam Pharmaceuticals’ Bottom Line Trend Indicates

Alnylam Pharmaceuticals’ (ALNY) interest income increased from $2.58 million in the second quarter of 2017 to $6.1 million in the second quarter of 2018.